Technology improvements have benefited the medical industry, especially in the area of diabetes prediction. In order to find patterns and risk factors related to diabetes, machine learning and Artificial Intelligence (AI) are vital in the analysis of enormous volumes of data, including medical records, lifestyle variables, and biomarkers. This makes it possible for tailored management and early discovery, which might revolutionize healthcare. This study examines how machine learning algorithms may be used to identify diseases, with an emphasis on diabetes prediction. The Proposed Diabetes Prediction Empowered with Mutli-level Data Fusion and Machine Learning (DPEMDFML) model combines two distinct types of models-the Artificial Neural Network (ANN) and the Support Vector Machine (SVM)-to create a fused machine learning technique. Two separate datasets were utilized for training and testing the model in order to assess its performance. To ensure a thorough evaluation of the model's prediction ability, the datasets were split in two experiments in proportions of 70:30 and 75:25, respectively. The study's findings were encouraging, with the ANN algorithm obtaining a remarkable accuracy of 97.43%. This indicates that the model accurately identified instances of diabetes, indicating a high degree of accuracy. A more thorough knowledge of the model's prediction ability would result from further assessment and validation of its performance using various measures.